Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 20223 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-20223 views
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study Read more about Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study2 views
Surveillance of adverse events following immunisation in Australia, 2022 Submitted by scott.mair@hea… on Thu, 08/05/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, 202222 views
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial Read more about Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial12 views
Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia Read more about Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia11 views
Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations Read more about Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations9 views
Accelerated Bacille Calmette-Guérin reactions: more than meets the eye Read more about Accelerated Bacille Calmette-Guérin reactions: more than meets the eye20 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021 Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 202122 views
Surveillance of adverse events following immunisation in Australia annual report, 2021 Read more about Surveillance of adverse events following immunisation in Australia annual report, 202125 views
